Related Experiment Video

Updated: Jul 9, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Quality of life after liver transplantation for acute hepatic failure

James D Perkins1

  • 1Liver Transplantation Worldwide, University of Washington Medical Center, Seattle, WA, USA.

Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
|December 13, 2007
PubMed

Insights

Liver transplantation for acute liver failure (ALF) offers a good quality of life post-surgery. Recovery can be challenging due to physical changes from critical illness and intensive care.

Area of Science:

  • Hepatology and Transplant Surgery
  • Patient-Reported Outcomes
  • Quality of Life Research

Background:

  • Liver transplantation is a successful treatment for chronic liver disease (CLD).
  • Limited data exists on health-related quality of life (HRQoL) after liver transplantation for acute liver failure (ALF).
  • ALF transplants constitute a significant proportion (16.6%) of UK liver transplantations.

Discussion:

  • This study qualitatively explored HRQoL in ALF transplant recipients using semi-structured interviews.
  • Phenomenological analysis revealed themes of physical changes (inactivity), recovery (health transition), lifestyle modifications, and outlook.
  • Initial recovery presented physical and emotional challenges due to multi-organ failure and intensive care.

Key Insights:

  • Most ALF liver transplant recipients reported a good quality of life post-transplant.
  • Their quality of life was often comparable to their pre-transplant lifestyle.
  • The recovery process was frequently difficult, impacted by critical illness sequelae.

Outlook:

  • Further quantitative research is needed to validate these qualitative findings.
  • Understanding patient experiences can inform post-transplant care strategies for ALF patients.
  • Focusing on managing physical and emotional challenges can improve long-term HRQoL.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...